Anne V. Yagolovich

Moscow, MOW 119234, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Long-Term Culture of U87MG Glioblastoma Cells Reprograms Metabolism, Impacts Aggressiveness and Alters Drug Responses.

Long-Term Culture of U87MG Glioblastoma Cells Reprograms Metabolism, Impacts Aggressiveness and Alters Drug Responses.

Journal: Cell biochemistry and biophysics

Published: July 05, 2026

Peptide-Functionalized Iron Oxide Nanoparticles for Cancer Therapy: Targeting Strategies, Mechanisms, and Translational Opportunities.

Peptide-Functionalized Iron Oxide Nanoparticles for Cancer Therapy: Targeting Strategies, Mechanisms, and Translational Opportunities.

Journal: Molecules (Basel, Switzerland)

Published: November 30, 2025

Codelivery of Bortezomib and Modified DR5-Selective TRAIL via Amphiphilic Poly(N-vinylpyrrolidone) Bionanocomposites to Overcome Glioblastoma Resistance.

Codelivery of Bortezomib and Modified DR5-Selective TRAIL via Amphiphilic Poly(N-vinylpyrrolidone) Bionanocomposites to Overcome Glioblastoma Resistance.

Journal: ACS applied bio materials

Published: November 24, 2025

Amphiphilic Poly(N-vinylpyrrolidone) Biocomposites with Bortezomib and DR5-Selective TRAIL Variants: A Promising Approach to Pancreatic Cancer Treatment.

Amphiphilic Poly(N-vinylpyrrolidone) Biocomposites with Bortezomib and DR5-Selective TRAIL Variants: A Promising Approach to Pancreatic Cancer Treatment.

Journal: International journal of molecular sciences

Published: October 17, 2025

Synergistic effect of DR5-targeted capsules loaded with doxorubicin in drug-resistant 3D tumour spheroids.

Synergistic effect of DR5-targeted capsules loaded with doxorubicin in drug-resistant 3D tumour spheroids.

Journal: Journal of microencapsulation

Published: October 14, 2025

Senolytic Properties of DR5-Selective TRAIL in Pancreatic Cancer Cell Lines.

Senolytic Properties of DR5-Selective TRAIL in Pancreatic Cancer Cell Lines.

Journal: Acta naturae

Published: October 10, 2025

Novel Fusion Protein Based on DR5-Specific TRAIL Variant with Enhanced Antitumor Properties.

Novel Fusion Protein Based on DR5-Specific TRAIL Variant with Enhanced Antitumor Properties.

Journal: Biochemistry. Biokhimiia

Published: October 09, 2025

Assessment of the angiogenic potential of xenografted tumors by biomedical imaging techniques.

Assessment of the angiogenic potential of xenografted tumors by biomedical imaging techniques.

Journal: Biomedical optics express

Published: September 04, 2025

Temozolomide-induced senescent glioblastoma cells acquire sensitivity to TRAIL death receptor 5-mediated apoptosis.

Temozolomide-induced senescent glioblastoma cells acquire sensitivity to TRAIL death receptor 5-mediated apoptosis.

Journal: Medical oncology (Northwood, London, England)

Published: July 04, 2025

Multivalent fusion protein targeting VEGFR2 and DR5 receptors: assessing the antiangiogenic and antitumor effects via multimodal microangiography.

Multivalent fusion protein targeting VEGFR2 and DR5 receptors: assessing the antiangiogenic and antitumor effects via multimodal microangiography.

Journal: Journal of translational medicine

Published: February 28, 2025

Glioblastoma Sensitization to Therapeutic Effects by Glutamine Deprivation Depends on Cellular Phenotype and Metabolism.

Glioblastoma Sensitization to Therapeutic Effects by Glutamine Deprivation Depends on Cellular Phenotype and Metabolism.

Journal: Biochemistry. Biokhimiia

Published: November 10, 2024

Enhancing Tumor Targeted Therapy: The Role of iRGD Peptide in Advanced Drug Delivery Systems.

Enhancing Tumor Targeted Therapy: The Role of iRGD Peptide in Advanced Drug Delivery Systems.

Journal: Cancers

Published: October 08, 2024

Showing 1-12 of 28

Last Updated: 09/26/2026